Robert Sosnowski
Nessuna posizione attualmente
Profilo
Robert Edward Sosnowski founded Dexgen Pharmaceuticals, Inc. in 2000, where he worked as President & Chief Executive Officer.
Mr. Sosnowski also formerly worked at Algos Pharmaceutical Corp., as Vice President-Sales & Marketing and Cyclacel Pharmaceuticals, Inc., as Vice President-Sales & Marketing in 2012.
Mr. Sosnowski received his undergraduate degree in 1980 from the University of Connecticut.
Precedenti posizioni note di Robert Sosnowski
| Società | Posizione | Fine |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Vendite & Marketing | 30/06/2012 |
Algos Pharmaceutical Corp.
 Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Vendite & Marketing | - |
| Dexgen Pharmaceuticals, Inc. | Fondatore | - |
Formazione di Robert Sosnowski
| University of Connecticut | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Dexgen Pharmaceuticals, Inc. | |
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
- Borsa valori
- Insiders
- Robert Sosnowski
